GLP or GCP for bioanalysis? [GxP / QC / QA]

posted by ElMaestro  – Denmark, 2019-01-20 11:42 (821 d 15:44 ago) – Posting: # 19787
Views: 4,648

Hi all,

more confusion at my end, it is something very basic.

EU guideline on BE: "The bioanalytical part of bioequivalence trials should be performed in accordance with the principles of Good Laboratory Practice (GLP)"

EU guideline on method validation: "The validation of bioanalytical methods and the analysis of study samples for clinical trials in humans should be performed following the principles of Good Clinical Practice (GCP)"

So, which guideline(s) must a CRO follow for sample analysis for EU studies: GLP or GCP or both?
Does validation "only" need to comply with GCP and if yes, can you give a practical example of the real difference?

If you are saying both GLP and GCP need to be observed in some cases then I may have a natural question about the meaning of the term "principal investigator"....:-)

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 14 (0 registered, 14 guests [including 3 identified bots]).
Forum time: Wednesday 04:26 CEST (Europe/Vienna)

In the Middles Ages the lingua franca of science was Latin.
Nowadays the language of science is bad English.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5